CATEGORIES: Awareness | CMT Update

Disease Awareness Problem

by | Mar 23, 2017 | 2 comments

Charcot-Marie-Tooth Disease Awareness Problem from Hereditary Neuropathy Foundation on Vimeo.

If you walked up to a group of people in your town, your city, your school, or your neighborhood…and asked them if they ever heard about Multiple Sclerosis, the majority would say, “Yes.”

Now, ask them if they have ever heard of Charcot- Marie-Tooth…the majority would say “What?”

Even though the incidence of CMT is greater than that of MS and other diseases, CMT goes largely unrecognized–and not just among the general population. Patients go years without a proper diagnosis and care because many health care professionals (HCPs) are not aware of the disease or how to manage it.

Why are we still battling a disease awareness problem? This critical issue of disease was addressed in the closing keynote at the 2016 Patient-Centered Charcot-Marie- Tooth Summit. Robert Moore, husband to Allison Moore, CEO and Founder of HNF, led a compelling discussion on the challenges of CMT awareness and how we–as a community of patients, researchers, and HCPs– can give this disease the recognition it deserves. He encouraged us to keep pushing the boundaries of raising awareness within the CMT patient and HCP communities. Without awareness, we don’t have a voice.

You won’t want to miss this video of Robert, who not only educated but entertained the audience with his engaging keynote.

Learn more on this topic

Related Blog Posts

Scientific Advisory Board Meeting

Scientific Advisory Board Meeting

On the 7th of November we convened our scientific advisory board meeting at the HNF offices in NY. We have written a detailed review that has been published and captures all of the discussion and make this freely available to the scientific community.

Breaking News: First Therapeutic Gene Therapy to Treat an Inherited Neuropathy is Approved for Clinical Trial!

The first disease community to receive a therapeutic gene to the spinal cord for an ultra rare inherited neuropathy is Giant Axonal Neuropathy (GAN). Congratulations to Hannah’s Hope Fund (HHF), a 501(c)3 public charity, which has driven this collaborative research in less than six years. Six million dollars has been raised to date to fund pre-clinical and clinical research on this rare disease.

A Rare Disease Patient That Does It All!

A movie script could not play out like this. There are very few occasions when a rare disease patient becomes the topic of a story that is truly uplifting. Often the stories are tragic or disheartening. That was not the case, however, with CMT patient Kim Goodsell.

Hot Off the Press

One of the ways that some CMT patients first become aware of their disease is when they are given a drug treatment for another disease. This is termed chemotherapy-induced neurotoxicity. Drugs such as paclitaxel and the vinca alkaloids that are widely used in cancer treatment cause severe peripheral neuropathy and in some patients this exacerbates CMT, revealing it perhaps for the first time.

Kara Q&A: How to “support” a friend or family member that’s affected with Charcot-MarieTooth.

My name is Courtney Hollett, Fundraising Coordinator at the Hereditary Neuropathy Foundation. This time of year I count my blessing daily and wanted to share with you a Q&A session I had with a new supporter of HNF. Kara, like myself has many family members affected with CMT and I reached out to her to share her thoughts and advice about how to “support” a friend or family member that’s affected with Charcot-MarieTooth.

Collaboration is the Key to HNF Success

Collaboration is the Key to HNF Success

We at HNF are so proud of the accomplishments of those scientists we fund and are asking you to please continue to support our efforts. Our Therapeutic Research In Accelerated Discovery (TRIAD) program is a proven collaborative model in the drug discovery process.

Join the conversation

Leave a Comment

2 Comments

  1. Annette Weber

    Great presentation Rob-I learned so very much about the ordeal of this diagnosis.
    You made a great point of what we don’t know-we don’t think about and don’t try
    to understand. You were very informative about illness vey similar to CMT that
    we are all familiar with. I know your presentation inpacted my understanding and
    how to help—just spread the word about CMT and help make it a treatable illness
    that is commonly understood. Thank you Robert- this was a very personal and
    compassionate plea.

    Reply
  2. Danielle Zygmant

    There are many things we as a community are learning that we have in common, and I have had many doctors tell me things arent linked and they clearly are…its frustrating…my son has pectus carinatum as do I and so on, toe walking is a very big indicator too.

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news